In contrast to the general population, in which the lifetime risk of developing ovarian carcinoma is 1.6% (average age at diagnosis 63 years), women carrying a BRCA1 mutation have a lifetime risk of 35–60% with an average age of diagnosis of 50 years [2]. This evidence concerns the gene BRCA1 and ovarian carcinoma.